0001758604-20-000001.txt : 20200521 0001758604-20-000001.hdr.sgml : 20200521 20200521103346 ACCESSION NUMBER: 0001758604-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200521 DATE AS OF CHANGE: 20200521 EFFECTIVENESS DATE: 20200521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Good Therapeutics, Inc. CENTRAL INDEX KEY: 0001758604 IRS NUMBER: 811139952 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-326349 FILM NUMBER: 20900535 BUSINESS ADDRESS: STREET 1: 4317 DENSMORE AVE. N. CITY: SEATTLE STATE: WA ZIP: 98103 BUSINESS PHONE: 425-591-9641 MAIL ADDRESS: STREET 1: 4317 DENSMORE AVE. N. CITY: SEATTLE STATE: WA ZIP: 98103 D/A 1 primary_doc.xml X0708 D/A LIVE 0001758604 Good Therapeutics, Inc. 454 N. 34th St., 1st Floor Seattle WA WASHINGTON 98103 425-591-9641 DELAWARE None None Corporation true 2016 John Mulligan c/o Good Therapeutics, Inc. 454 N. 34th St., 1st Floor Seattle WA WASHINGTON 98103 Executive Officer Director Promoter John McKearn c/o Good Therapeutics, Inc. 454 N. 34th St., 1st Floor Seattle WA WASHINGTON 98103 Director Mitchell Mutz c/o Good Therapeutics, Inc. 454 N. 34th St., 1st Floor Seattle WA WASHINGTON 98103 Director Karl Handelsman c/o Good Therapeutics, Inc. 454 N. 34th St., 1st Floor Seattle WA WASHINGTON 98103 Director Nicholas Walrod c/o Good Therapeutics, Inc. 454 N. 34th St., 1st Floor Seattle WA WASHINGTON 98103 Director Biotechnology Decline to Disclose 06b true 0001758604-19-000001 2018-11-09 true true false 0 22335003 22335003 0 false 6 0 0 0 false Good Therapeutics, Inc. /s/ John Mulligan John Mulligan Chief Executive Officer 2020-05-21